No Data
No Data
Longeveron Inc. CEO Wa'el Hashad to Present at Biotech Showcase 2025 on January 14
Longeveron Initiated With a Buy at Roth MKM
H.C. Wainwright Maintains Longeveron(LGVN.US) With Buy Rating, Cuts Target Price to $10
Longeveron Initiated at Buy by Roth MKM
Longeveron Price Target Announced at $10.00/Share by Roth MKM
Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024
GoldenRam : comatose ? hope they can find a cure for eomething soon.